Gulce Solakoglu
Endocrinology, Diabetes & Metabolism · Manning, SCNPI 1952963993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $994, more than ten times the $91 reported in 2023. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in SC, where the typical reported total is $2,665.
Across 48 payments — averaging $33.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$277
- Novo Nordisk$214
- Abbott$166
- Corcept Therapeutics$121
- Medtronic$107
- Cequr Corporation$98
- plus $639 from 15 others
What the payments were for
- Food & beverage$1,623100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 6 | $277 |
| Novo Nordisk | 3 | $214 |
| Abbott | 2 | $166 |
| Corcept Therapeutics | 5 | $121 |
| Medtronic | 2 | $107 |
| Cequr Corporation | 1 | $98 |
| Amgen | 3 | $92 |
| Dexcom, Inc. | 3 | $72 |
| Recordati_rare_diseases_inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $57 |
| Ascendis Pharma Endocrinology Inc | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Tandem Diabetes Care, Inc. | 2 | $47 |
| Radius Health, Inc. | 1 | $34 |
| Chiesi USA, Inc. | 1 | $28 |
| Ascensia Diabetes Care US Inc. | 1 | $26 |
| Sequel Med Tech, LLC | 1 | $18 |
| Bayer | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$150
- FREESTYLE LIBRE 3$150
How this compares
$1,623 in reported general payments places this provider in the 40th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
See all endocrinology, diabetes & metabolism providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gvoke Hypopen 1-PackGlucagon | 11 | $3,429 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,175 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Manning
- Gauri DhirMyrtle Beach$417K
- Cory WhiteGreenville$413K
- Louis HaenelCharleston$377K
- Vonda CalcuttWalterboro$368K
- Ray VaughtersAiken$321K
- Donald EagertonMyrtle Beach$284K
- Beatrice HullCharleston$214K
- Joseph MathewsSummerville$168K
- Brittany HendersonMount Pleasant$157K
- Zouhair BibiConway$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.